Brewerton T D, Jimerson D C
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425-0742, USA.
Psychiatry Res. 1996 Apr 16;62(1):31-42. doi: 10.1016/0165-1781(96)02987-3.
Neuroendocrine, temperature, test-meal, and psychometric responses are reviewed following challenges with the post-synaptic 5-HT receptor agonist m-chlorophenylpiperazine (m-CPP), the 5-HT precursor L-tryptophan (L-TRP), and placebo in 12 patients with anorexia nervosa (AN) and 16 healthy controls. A subset of the AN patients (n = 8) were rechallenged 3-4 weeks after attaining a predetermined goal weight. AN patients had blunted prolactin (PRL) responses to both m-CPP and L-TRP at low-weight and at goal-weight in comparison to controls, although there was a tendency toward normalization with weight gain. There were trends for blunted growth hormone (GH) responses following both L-TRP and m-CPP in the low-weight but not the goal-weight AN patients. Cortisol (CORT) responses following m-CPP and L-TRP were not significantly different among any of the groups. Temperature and test-meal measures were largely unaffected by serotonergic agents in the patients, although m-CPP decreased meal size in the controls. Psychometric responses were variable and are briefly described. Taken together, these findings indicate that responsiveness in post-synaptic hypothalamic-pituitary serotonergic pathways is altered in AN patients. Although there were some trends toward normalization of responsiveness following goal-weight attainment, many differences tended to persist in the patients despite an average increase of 13 kilograms. These may represent changes in serotonergic function at levels in the CNS "above" the hypothalamus.
在12名神经性厌食症(AN)患者和16名健康对照者中,分别用突触后5-羟色胺(5-HT)受体激动剂间氯苯哌嗪(m-CPP)、5-HT前体L-色氨酸(L-TRP)和安慰剂进行激发试验后,对神经内分泌、体温、试餐及心理测量反应进行了回顾。一部分AN患者(n = 8)在达到预定目标体重后3 - 4周再次接受激发试验。与对照组相比,AN患者在低体重和目标体重时对m-CPP和L-TRP的催乳素(PRL)反应均减弱,不过随着体重增加有恢复正常的趋势。低体重而非目标体重的AN患者在接受L-TRP和m-CPP后生长激素(GH)反应有减弱趋势。m-CPP和L-TRP后的皮质醇(CORT)反应在任何组间均无显著差异。患者的体温和试餐指标在很大程度上不受血清素能药物影响,尽管m-CPP使对照组的进餐量减少。心理测量反应各不相同,在此简要描述。总体而言,这些发现表明AN患者突触后下丘脑 - 垂体血清素能通路的反应性发生了改变。尽管达到目标体重后反应性有一些恢复正常的趋势,但尽管平均体重增加了13千克,患者中许多差异仍趋于持续存在。这些可能代表中枢神经系统中“下丘脑以上”水平的血清素能功能变化。